SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
PharmaGap Inc. Announces Results of In Vivo Study at the Ottawa Health Research Institute Testing the Effect of the Company's Lead Drug on Ovarian Cancer